InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference
InspireMD (Nasdaq: NSPR), the developer of the CGuard™ Prime carotid stent system for treating carotid artery disease and stroke prevention, has announced its upcoming participation at the Bank of America 2025 Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InspireMD (Nasdaq: NSPR), the developer of the CGuard™ Prime carotid stent system for treating carotid artery disease and stroke prevention, has announced its upcoming participation at the Bank of America 2025 Healthcare Conference.
The presentation is scheduled for Wednesday, May 14, 2025, at 1:15PM Eastern Time (10:15AM Pacific Time). Interested parties can access both the live audio webcast and a 90-day replay through the "News & Events" section on InspireMD's official website at inspiremd.com/en/events/.
Positive
- Company gains visibility through presentation at major Bank of America healthcare conference
Negative
- None.
Details
News Market Reaction – NSPR
The recorded move for NSPR in the trading session of this news was +3.53%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the Bank of America 2025 Healthcare Conference on Wednesday, May 14, 2025, at 1:15PM Eastern Time / 10:15AM Pacific Time.
A live audio webcast and replay of the presentation may be accessed for 90 days on the “News & Events” section of the company’s website at: https://www.inspiremd.com/en/events/
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com
Webb Campbell
Gilmartin Group LLC
webb@gilmartinir.com
investor-relations@inspiremd.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.